Cabozantinib for the treatment of patients with metastatic non-clear cell renal cell carcinoma: A retrospective analysis

Campbell, MT; Bilen, MA; Shah, AY; Lemke, E; Jonasch, E; Venkatesan, AM; Altinmakas, E; Duran, C; Msaouel, P; Tannir, NM

Campbell, MT (reprint author), Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Box 1374,1515 Holcombe Blvd, Houston, TX 77030 USA.

EUROPEAN JOURNAL OF CANCER, 2018; 104 (): 188

Abstract

Background: Cabozantinib prolongs overall survival (OS) and progression-free survival (PFS) in patients with metastatic clear cell renal cell carcinom......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索